CD8A and cancer: In BC, peripheral CD8+ T cells exist in naive form and need to be activated by dendritic cells with tumor‐specific antigen in lymphoid tissues,26 then those CD8+ T cells become effector T cells, which could bind to tumor cells' surface antibody, and release lytic granules to kill target cancer cells.27